Urology
Volume 72, Issue 5 , Pages 1125-1129, November 2008

Does Timing of Androgen Deprivation Influence Radiation-Induced Toxicity? A Secondary Analysis of Radiation Therapy Oncology Group Protocol 9413

This study was presented as a poster at the American Society for Therapeutic Radiology and Oncology Annual Meeting, Philadelphia, November 2006.

  • Daniel Taussky

      Affiliations

    • Department of Radiation Oncology, Montreal University, Montreal, Quebec, Canada
    • Corresponding Author InformationReprint requests: Daniel Taussky, M.D., Department of Radiation Oncology, Centre Hospitalier Universitaire de Montréal Hôpital Notre-Dame, 1560 Sherbrooke Street East, Montreal, H2L 4M1 QC Canada
    • ,
  • Kyounghwa Bae

      Affiliations

    • Department of Statistics, Radiation Therapy Oncology Group, Philadelphia, Pennsylvania
    • ,
  • Jean-Paul Bahary

      Affiliations

    • Department of Radiation Oncology, Montreal University, Montreal, Quebec, Canada
    • ,
  • Mack Roach III

      Affiliations

    • Department of Radiation Oncology, University of California, San Francisco, School of Medicine, San Francisco, California
    • ,
  • Colleen A. Lawton

      Affiliations

    • Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin
    • ,
  • William U. Shipley

      Affiliations

    • Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts
    • ,
  • Howard M. Sandler

      Affiliations

    • Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, Michigan

Received 3 August 2007; accepted 13 November 2007. published online 04 March 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This study supported by RTOG U10, CA21661, CCOP U10 CA37422, and Stat U10 CA32115 grants from the National Cancer Institute.

 M. Roach is a study investigator funded by GlaxoSmithKline; is a paid consultant to Astra-Zeneca; and is a member of the speaker's bureau for TAP Pharmaceuticals and Siemens.

PII: S0090-4295(07)02448-X

doi:10.1016/j.urology.2007.11.067

Urology
Volume 72, Issue 5 , Pages 1125-1129, November 2008

Article Tools